Follow the Rain Oncology Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €12.2m. The latest transaction was reported on 2 February 2024 (U). Among the most active insiders: TANG KEVIN C. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
€408,680
2 ops.
Buy Volume
€1m
2 ops.
Sell Volume
14Σ signal
Buys €408,680€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
995,000 shares@ US$1.25100.0% of flowCommon StockSEC:0000895345-23-000356:0
11 of 11 declarations
About Rain Oncology Inc.
Rain Oncology Inc. is a biotechnology company focused on developing treatments for cancer. It concentrates on targeted therapies and innovative approaches to improve patient outcomes.